Published in Eur J Pharmacol on May 12, 1993
Blockade by ifenprodil of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions. Br J Pharmacol (1994) 1.06
An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones. Eur J Pharmacol (2007) 0.90
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors. PLoS One (2012) 0.89
The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan. Br J Pharmacol (2005) 0.82
Low concentrations of neuroactive steroids alter kinetics of [3H]ifenprodil binding to the NMDA receptor in rat frontal cortex. Br J Pharmacol (2005) 0.77
Characterization of pulmonary sigma receptors by radioligand binding. Eur J Pharmacol (2015) 0.76
GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia. BMC Psychiatry (2014) 0.75
Old drug ifenprodil, new hope for PTSD with a history of childhood abuse. Psychopharmacology (Berl) (2013) 0.75
Hyperactivity of Hypothalamic-Pituitary-Adrenal Axis Due to Dysfunction of the Hypothalamic Glucocorticoid Receptor in Sigma-1 Receptor Knockout Mice. Front Mol Neurosci (2017) 0.75
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
Gender-linked brain injury in experimental stroke. Stroke (1998) 3.08
Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (1988) 3.01
Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia (2000) 2.82
Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75
Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience (2009) 2.38
Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67
Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology (2001) 1.61
17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke (1999) 1.58
The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48
Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain. Anesthesiology (1989) 1.47
Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 1.46
Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41
The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 1.38
Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry (2008) 1.25
Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21
Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20
Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain (1983) 1.08
Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry (2007) 1.05
Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience (1991) 1.04
2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem (1998) 1.04
Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res (1990) 1.03
Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry (2008) 1.01
Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke (1998) 0.98
Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98
Differential effects of age on motor performance in two mouse strains. Neurobiol Aging (1981) 0.98
2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol (1998) 0.98
Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci (1997) 0.97
Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology (Berl) (1996) 0.95
[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther (1997) 0.95
Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology (1995) 0.94
Radial maze performance in young and aged mice: neurochemical correlates. Pharmacol Biochem Behav (1985) 0.94
Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett (1985) 0.94
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke (1996) 0.93
sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke (2000) 0.93
Effects of L-cocaine on local cerebral glucose utilization in the rat. Neurosci Lett (1986) 0.92
Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur J Pharmacol (1998) 0.91
6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci (2000) 0.91
Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab (2009) 0.90
In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci (1998) 0.90
Aging and caloric restriction in nonhuman primates: behavioral and in vivo brain imaging studies. Ann N Y Acad Sci (2001) 0.90
Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res (1987) 0.90
Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Res (1992) 0.89
Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging. Neurobiol Aging (2000) 0.89
Sigma receptors in post-mortem human brains. J Pharmacol Exp Ther (1988) 0.89
Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol (1997) 0.89
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke (1995) 0.89
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand. Neuroreport (1998) 0.89
High affinity binding of [3H]epibatidine to rat brain membranes. Neuroreport (1999) 0.88
Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. Biol Psychiatry (1981) 0.88
Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry (1991) 0.88
No effect of hyperketonemia on local cerebral glucose utilization in conscious rats. J Neurochem (1982) 0.88
Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci (1994) 0.88
Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging. Pharmacopsychiatry (2003) 0.87
Postischemic brain injury is affected stereospecifically by pentazocine in rats. Anesth Analg (1997) 0.87
Aging alters the circadian rhythm of glucose utilization in the suprachiasmatic nucleus. Proc Natl Acad Sci U S A (1988) 0.86
Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology (Berl) (1995) 0.86
Loss of D2 receptor binding with age in rhesus monkeys: importance of correction for differences in striatal size. J Cereb Blood Flow Metab (1999) 0.86
[AIDS and sleep disorders: effect of gp120 on cerebral glucose metabolism]. C R Seances Soc Biol Fil (1989) 0.85
Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats. Anesth Analg (1998) 0.85
Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. J Nucl Med (1997) 0.84
Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology (2001) 0.84
Further characterization of [3H]ifenprodil binding in rat brain. Eur J Pharmacol (1994) 0.84
New pharmacological strategies for cognitive enhancement using a rat model of age-related memory impairment. Ann N Y Acad Sci (1994) 0.84
Learning in a 14-unit T-maze is impaired in rats following systemic treatment with N omega-nitro-L-arginine. Eur J Pharmacol (1998) 0.83
In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine. Synapse (1995) 0.83
Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J Pharmacol Exp Ther (1991) 0.83
Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor. Eur J Pharmacol (1990) 0.83
Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse (2000) 0.83
Dietary restriction suppresses age-related changes in dendritic spines. Neurobiol Aging (1989) 0.83
Effects of morphine on the phenotypic expression of cell surface markers on murine lymphocytes. Life Sci (1992) 0.83
Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement. Mol Psychiatry (2011) 0.82
Age and neurochemical correlates of radial maze performance in rats. Neurobiol Aging (1981) 0.82
Phylogenetic distribution of [3H]kainic acid receptor binding sites in neuronal tissue. Brain Res (1980) 0.82
Altered cerebral glucose utilization following blood-brain barrier opening by hypertonicity or hypertension. Exp Neurol (1981) 0.82
Cerebral glucose utilization is reduced in second test session. J Cereb Blood Flow Metab (1997) 0.82
Diurnal rhythmicity and hypothalamic deficits in glucose utilization in aged ovariectomized rats. J Neurosci (1987) 0.81
Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. Nucl Med Biol (1999) 0.81
Correlation of inhibitory potencies of putative antagonists for sigma receptors in brain and spleen. Eur J Pharmacol (1988) 0.81
Morphine decreases cerebral glucose utilization in limbic and forebrain regions while pain has no effect. Neuropharmacology (1991) 0.81
Arterial-venous differences in plasma concentrations of nicotine after cigarette smoking. JAMA (1990) 0.81
Intracerebroventricular injection of N omega-nitro-L-arginine in rats impairs learning in a 14-unit T-maze. Eur J Pharmacol (1998) 0.81
Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors. Eur J Pharmacol (1995) 0.81
Cocaine-induced increases in EEG alpha and beta activity: evidence for reduced cortical processing. Neuropsychopharmacology (1994) 0.81
Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology (1995) 0.80
Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients. Can J Neurol Sci (1986) 0.80
Effect of cocaine-related environmental stimuli on the spontaneous electroencephalogram in polydrug abusers. Neuropsychopharmacology (1998) 0.80
Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors. J Nucl Med (1997) 0.80
Effects of aging and chronic nimodipine on hippocampal binding of [3H]CGS 19755. Neurobiol Aging (1996) 0.80
2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. Neuroreport (1999) 0.80
Co-dergocrine, cerebral glucose utilization and maze performance in middle-aged rats. Pharmacol Biochem Behav (1987) 0.80
Neuroimaging placebo effects: new tools generate new questions. Clin Pharmacol Ther (2009) 0.80
Cerebral blood flow and glucose utilization following opening of the blood-brain barrier and during maturation of the rat brain. Fed Proc (1981) 0.80
Palmitate incorporation into different brain regions in the awake rat. Brain Res (1983) 0.80
Radiosynthesis, cerebral distribution, and binding of [125I]-1-(p-iodophenyl)-3-(1-adamantyl)guanidine, a ligand for sigma binding sites. J Med Chem (1992) 0.80
Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Neuropharmacology (1989) 0.79
Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction. J Pharmacol Exp Ther (1978) 0.79